Press release
Pulmonary Drug Delivery Systems Market Expected to Reach $49.7 Billion by 2030
Pulmonary drug delivery is a targeted drug delivery system which is precisely designed for the inhalation with the help of a device called Aerosol. It plays an important role in managing Asthma and COPD. On the basis of type the market is divided into nebulizer, metered dose inhaler, and dry powder inhaler. PDDS gives quick relief in obstructive pulmonary diseases and can be lifesaving in case of an asthmatic attack.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/2944
Increase in air pollution leads to rise in respiratory disorders which fosters the growth of the pulmonary drug delivery systems market. However, the problems related to the formulation stability & high price of aerosol containers limit its usage.
Factors that drive the growth of the global pulmonary drug delivery systems market include rise in the prevalence of pulmonary diseases, advancement in technologies and surge in demand for respiratory care products. Furthermore, the rise in concerns for respiratory health contributes toward the growth of the global market. According to Global Asthma Network, 339 million people are affected by asthma, in 2018.
Moreover, rise in respiratory diseases and advancements in the latest technology are anticipated to drive the growth of the global pulmonary drug delivery systems market. Furthermore, the increase in demand for effective, fast, and accurate treatment results have led to the development of advanced PDDS, thereby propelling the growth of the market.
Moreover, initiatives taken by the governments for pulmonary disease treatment and increase in the number of hospitals are the key factors that boost the growth of the market. Furthermore, development of the healthcare sector and increase in awareness about the respiratory health propel the growth of the market.
The global pulmonary drug delivery systems market is segmented into product, application, and distribution channel. On the basis of product, the market is divided into dry powder inhaler, metered dose inhaler, and nebulizer. The metered dose inhaler segment dominated the market in 2020, and this trend is expected to remain dominant during the forecast period, owing to the development of devices, increase in number of diagnostic centers, and rise in pulmonary diseases
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/2944
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Hip Orthosis Market -- https://www.alliedmarketresearch.com/hip-orthosis-market
Coagulation Testing Market -- https://www.alliedmarketresearch.com/coagulation-testing-market
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Drug Delivery Systems Market Expected to Reach $49.7 Billion by 2030 here
News-ID: 2994431 • Views: โฆ
More Releases from Allied Market Research
Global DNA Vaccine market to Hit $774.43M by 2030 (6.3% CAGR) Driven by Rising C โฆ
DNA vaccines represent a groundbreaking approach to immunization, leveraging the power of genetics to stimulate a robust immune response. Unlike traditional vaccines that use weakened or inactivated pathogens, DNA vaccines introduce a small piece of genetic material to instruct cells to produce specific proteins that trigger an immune response. This article explores the potential of DNA vaccines, highlighting their unique advantages, advancements, and the transformative impact they may have onโฆ
Aviation Weather RADAR Market Strategies, In-depth Analysis, Key Players and Geo โฆ
The aviation weather RADAR system is the tool used by pilots for strategic and tactical planning of a safe flight trajectory. Each aircraft has a radar antenna mounted in the nose of the aircraft. This antenna catches signals, which are then processed by a computer, enabling the pilots to view the same and make necessary weather predictions. Since the aviation industry is highly competitive, the generated profits are attributed toโฆ
Chocolate Couverture Market by Growth, Emerging Trends and Forecast by 2023-2032
Chocolate couverture is high-quality chocolate with extra cocoa butter, which imparts glossy texture, and is used to cover sweets and cakes. Couverture chocolate bars contain cocoa solids, cocoa butter, sugar, and other basic chocolate bar ingredients. The major change is with the texture of cocoa that is ground to a finer texture than regular chocolates and contains more cocoa butter. Various forms of chocolate coverture are available in the marketโฆ
Trends in Polyvinyl Butrayl (PVB) Films for Automobile Market 2026: Transforming โฆ
As per the report published by Allied Market Research, the global polyvinyl butrayl (PVB) films for automobile market was pegged at $189.2 million in 2021, and is expected to reach $227.8 million by 2031, growing at a CAGR of 4.7% from 2022 to 2031.
The report provides an in-depth analysis of top segments, changing market trends, value chain, key investment pockets, competitive scenario, and regional landscape. The report isโฆ
More Releases for Pulmonary
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,โฆ
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary โฆ
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offersโฆ
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOCโฆ
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend ofโฆ
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market โ Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treatedโฆ
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic โฆ
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segmentsโฆ
